Rebeauty Atlas는 무엇인가요?

Rebeauty Atlas는 AI·디자인·마케팅·경제·의료 등 다양한 주제의 Medium 아티클을 수집해 태그·트랙·위키·인사이트로 탐색할 수 있게 정리한 리서치 아카이브입니다.

글은 어떻게 모이나요?

Rebeauty Atlas는 Medium에 공개된 아티클을 자동 수집해 AI·디자인·마케팅·경제·의료 등 주제별 태그·트랙·위키로 정리하는 리서치 아카이브입니다.

사이트는 어떤 섹션으로 구성되어 있나요?

Articles · Wiki · Insights · Tags 섹션으로 구성되어 있으며, PHP MVC · MySQL · shadcn-style UI · Wiki via keyword rules 로 만들어졌습니다.

Articles · Rebeauty Atlas

ECO

AB Abhishek kumar

📊 Top HEOR Analysis Firms Powering Better Healthcare Decisions

HEOR analysis firms play a key role in proving treatment value and strengthening market access strategies. DelveInsight provides HEOR…

May 18, 2026 · 0 min read · 0 claps #heor

MED

AB Abhishek kumar

Building the Evidence Base That Connects Innovation to Patient Access

Innovation in medicine has never been more rapid. Gene therapies, targeted biologics, digital therapeutics, and precision oncology…

May 12, 2026 · 3 min read · 0 claps #heor

Building the Evidence Base That Connects Innovation to Patient Access

AI BIO ECO SCI

MA MadeAi

AI Agents Will Transform Regulatory Content into a Competitive Asset

In the life sciences, regulatory content has always played a critical role, yet it has rarely been treated as a strategic asset. Documents…

Apr 28, 2026 · 4 min read · 48 claps #agentic-ai #regulatory-affairs #market-access

AI Agents Will Transform Regulatory Content into a Competitive Asset

ECO SCI

SN Sneha Rai

Why NMA is the “GPS” of Evidence-Based Medicine

In the world of Health Economics and Outcomes Research (HEOR), we rarely face a simple “A vs. B” scenario. In reality, we’re dealing with a…

Apr 06, 2026 · 1 min read · 0 claps #heor #biostatistics #data

SPT ECO

AN Andrea Mantovani

THE EU HTA REGULATION AND JOINT CLINICAL ASSESSMENT: Turning Regulatory Promise into Market Access…

Executive Summary

Mar 20, 2026 · 9 min read · 1 claps paywalled #jca #market-access-strategy #euhta

TCH SOC

WH White Coat Writes

4 Game-Changing Free HEOR Certification :Open Doors & Eliminate Risk

Ever wondered how governments, hospitals, and pharma companies decide whether a drug is worth its price? That’s where HEOR steps in. Think…

Jan 05, 2026 · 0 min read · 0 claps #heor #antibiotics #free-certification

4 Game-Changing Free HEOR Certification :Open Doors & Eliminate Risk

ECO

FE Felipe Mainka

ESTIMATIVA DE CUSTOS DE MEDICAMENTOS NA PERSPECTIVA SUS

Segundo a diretriz brasileira de avaliação econômica, a definição da perspectiva do estudo é o pilar para a identificação dos custos a…

Sep 26, 2025 · 4 min read · 0 claps #us #banco-de-preços #at

ESTIMATIVA DE CUSTOS DE MEDICAMENTOS NA PERSPECTIVA SUS

ECO AI SCI

RO Rooting Research

Post-Hoc Analysis: The Science After the Science

The protocol is done. The endpoints are in. But the data isn’t finished talking. It still holds patterns you didn’t pre-specify, signals no…

Jul 30, 2025 · 6 min read · 0 claps #clinical-research #heor #post-hoc-analysis

Post-Hoc Analysis: The Science After the Science

ECO MED

MA Managementconsulting

Unlocking Pharmaceutical Market Access Strategies for Success

Introduction to Pharmaceutical Market Access

Jun 11, 2025 · 1 min read · 0 claps #pharmaceutical-market #heor

Unlocking Pharmaceutical Market Access Strategies for Success

SOC ECO

MO Molebedi Segwagwe · ZS Associates

Navigating EU HTAR: Strategies for success in joint clinical assessment

Learn about solutions HTDs can apply to address the main challenges raised by JCA through transforming planning and processes.

May 21, 2025 · 4 min read · 0 claps #european-union #market-access #health-economics